Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse SEMA3B ELISA Kit (AC2660)
Cat.#: ASET-1249
Specifications
Description Mouse SEMA3B ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse SEMA3B concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.058 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1337 Mouse Parkin ELISA Kit (AC2748) Quantitative inquiry ASET-1629 Mouse Ephrin A1 ELISA Kit (AC3040) Quantitative inquiry ASET-1950 Rat GRINA ELISA Kit (AC3361) Quantitative inquiry ASET-1565 Human BASP1 ELISA Kit (AC2976) Quantitative inquiry ASET-1843 Human CRCP ELISA Kit (AC3254) Quantitative inquiry ASET-1122 Rat CX3CR1 ELISA Kit (AC2533) Quantitative inquiry ASET-1127 Rat TRPV1 ELISA Kit (AC2538) Quantitative inquiry ASET-1789 Mouse VPAC2 ELISA Kit (AC3200) Quantitative inquiry ASET-1351 Mouse Myelin Basic Protein ELISA Kit (AC2762) Quantitative inquiry ASET-1464 Human L1CAM ELISA Kit (AC2875) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket